Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy

Name: Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy
License: Public Domain

Junling Li

ClinicalTrials.gov · Datasets · License: Public Domain

advanced non squamous nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 451462
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.